Category: UNMC SCC

Dr. Susan Swindells to lead new TB prevention clinical trial

We are very proud to have Dr. Susan Swindells as a part of our division. A nationally and internationally renowned HIV clinical researcher, Dr. Swindells is a Professor of Internal Medicine-Infectious Diseases at University of Nebraska Medical Center. For many years she has led the Specialty Care Center in providing extraordinary care to patients with […]

Jul 15, 2019

EMET Student Profile – Samantha Cox, M1

Meet Samantha Cox, a new M1 student in our HIV Enhanced Medical Education Track! Tell us a little about yourself I moved to Omaha with my family from Saskatoon, Saskatchewan, when I was in elementary school and attended high school at Duchesne Academy. I completed my Bachelor’s degree in French and Biology at College of […]

Jul 9, 2019

EMET Student Profile – Harrison Greene

Meet Harrison Greene, a new M1 student in our HIV Enhanced Medical Education Track! Tell us a little about yourself. I grew up in Omaha, Nebraska and graduated from Creighton Prep High School. I completed my undergraduate education at the University of Kansas, with a degree in Human Biology. During my last year at KU, […]

Apr 9, 2019

EMET Student Profile – Bianca Christensen

Our department is proud to participate in UNMC College of Medicine’s Enhanced Medical Education Track (EMET) program!  EMETs are enrichment opportunities to explore interdisciplinary fields of medicine with in small groups and with close faculty mentorship. Two students from each medical school class are selected to participate in our Comprehensive HIV Medicine EMET, a program […]

Mar 8, 2019

UNMC Division of Infectious Diseases – New Faculty Announcement

The Division of Infectious Diseases is pleased to announce the arrival of our newest Faculty members! Nada Fadul, MD Dr. Fadul will be supporting UNMC’s efforts on various Ryan White awards through the Specialty Care Center, where she will also serve as the Associate Medical Director. In addition, Dr. Fadul will support the General ID […]

Oct 22, 2018

Update for HIV Care Providers and Educators Revived and Reinvigorated!

Content written by Nikki Regan, APRN After a several year hiatus, the UNMC HIV Update conference was back and better than ever.  The conference planning committee at the UNMC/Nebraska Medicine Specialty Care Clinic started organizing this event over a year ago.  “The interest was definitely there,” said Ann Fitzgerald, APRN at the clinic and AIDS […]

Oct 12, 2018

At UNMC, ID fellows learn HIV from the experts

Over the course of their training, fellows in the UNMC’s Division of Infectious Diseases will receive dedicated clinical and didactic training in the area of HIV alongside faculty with expertise in the HIV clinical care and research. Clinical Training: Fellows will have their continuity clinic at UNMC’s HIV clinic one half day each week. The […]

Aug 30, 2018

Ending the AIDS epidemic with 90-90-90…Have YOU been tested?

Today is National HIV Testing Day, and one of the most fulfilling conversations to have with persons living with HIV (PLWH) is to share that since the 1980’s, we have made significant progress in the management of the AIDS epidemic. FDA approval of 27 antiretrovirals and 20 fixed dose combination antiretrovirals, increased HIV testing campaigns and […]

Jun 27, 2018

EMET Student Profile – Kevin Hanna, M1

Tell us about the position you are starting? I am a first-year medical student who is beginning the four year Enhanced Medical Education Track (EMET) program with a focus in HIV medicine. The program includes opportunities for preceptorships, seminars, volunteering, and research in HIV medicine culminating in a capstone research project and poster or conference presentation. […]

May 14, 2018

Pharm to Exam Table: Monoclonal Antibodies Make Their Way into HIV Treatment

Pharm to Exam Table: Clinical Pharmacology/Antimicrobial Updates – Trogarzo® (ibalizumab-uiyk), a new monoclonal antibody treatment approved for multi-drug resistant HIV-1  On March 6th 2018, the Food and Drug Administration approved a new monoclonal antibody called ibalizumab-uiyk, marketed under the tradename Trogarzo®. Ibalizumab-uiyk (IBA) is an intravenous treatment administered every two weeks. It is intended for use […]

May 11, 2018